Jornal Vascular Brasileiro
https://www.jvascbras.org/article/doi/10.1590/1677-5449.180105
Jornal Vascular Brasileiro
Guidelines

Diretrizes de conceito, diagnóstico e tratamento da trombose venosa superficial

Guidelines for superficial venous thrombosis

Marcelo José de Almeida; Ana Terezinha Guillaumon; Daniel Miquelin; Edwaldo Edner Joviliano; Ludvig Hafner; Marcone Lima Sobreira; Martin Andreas Geiger; Regina Moura; Selma Raymundo; Winston Bonnetti Yoshida;

Downloads: 1
Views: 33

Resumo

Resumo: A trombose venosa superficial (TVS), também denominada de tromboflebite superficial, caracteriza-se pela formação de trombos dentro de veias superficiais, com suboclusão ou oclusão da luz e reação inflamatória no seu trajeto, sendo mais comum nos membros inferiores. Afeta de 3 a 11% da população geral. O diagnóstico costuma ser clinicamente fácil, mas sua extensão e possíveis complicações tromboembólicas precisam de exames subsidiários para confirmação. A TVS pode estar associada a trombose venosa profunda em 6 a 40% dos casos, a embolia pulmonar assintomática (EP) em 20 a 33%, e a EP sintomática em 2 a 13%. Apesar de sua morbidade e das suas complicações, ainda não existem diretrizes brasileiras para a TVS. Nesta diretriz, foram analisadas as principais dúvidas quanto à definição, terminologia e etiologia da TVS, com recomendações para seu diagnóstico e tratamento.

Palavras-chave

guia de prática clínica, tromboflebites, flebites, trombose venosa, embolia pulmonar, veias

Abstract

Abstract: Superficial venous thrombosis (SVT) or superficial thrombophlebitis is characterized by thrombi within superficial veins, with partial involvement or occlusion of the lumen and inflammatory reaction along the course of the vein. Clinical diagnosis tends to be straightforward, but supplementary tests and examinations are needed to confirm thrombosis extension and possible thromboembolic complications. SVT can be associated with deep venous thrombosis in 6 to 40% of cases, with asymptomatic pulmonary embolism (PE) in 20 to 33%, and with symptomatic PE in 2 to 13%. Despite the morbidity and complications, there are currently no Brazilian guidelines for SVT. These guidelines cover the most important issues related to SVT definition, terminology, and etiology, and set out recommendations for diagnosis and treatment.
 

Keywords

clinical practice guidelines, thrombophlebitis, phlebitis, venous thrombosis, pulmonary embolism, veins

References

Schonauer V, Kyrle PA, Weltermann A, et al. Superficial thrombophlebitis and risk for recurrent venous thromboembolism. J Vasc Surg. 2003;37(4):834-8. http://dx.doi.org/10.1067/mva.2003.157. PMid:12663985.

Coon WW, Willis PW 3rd, Keller JB. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation. 1973;48(4):839-46. http://dx.doi.org/10.1161/01.CIR.48.4.839. PMid:4744789.

Sobreira ML, Yoshida WB, Lastória S. Tromboflebite superficial: epidemiologia, fisiopatologia, diagnóstico e tratamento. J Vasc Bras. 2008;7(2):131-43. http://dx.doi.org/10.1590/S1677-54492008000200007.

Kalodiki E, Stvrtinova V, Allegra C, et al. Superficial vein thrombosis: a consensus statement. Int Angiol. 2012;31(3):203-16. PMid:22634973.

Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e419S-96S. http://dx.doi.org/10.1378/chest.11-2301.

Di Nisio M, Wichers IM, Middeldorp S. Treatment for superficial thrombophlebitis of the leg. Cochrane Database of Systematic Reviews. 2013(4):CD0049. http://dx.doi.org/10.1002/14651858.CD004982.pub5.

Wichers IM, Di Nisio M, Buller HR, Middeldorp S. Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review. Haematologica. 2005;90(5):672-7. PMid:15921382.

Plate G, Eklof B, Jensen R, Ohlin P. Deep venous thrombosis, pulmonary embolism and acute surgery in thrombophlebitis of the long saphenous vein. Acta Chir Scand. 1985;151(3):241-4. PMid:4013602.

Bergqvist D, Jaroszewski H. Deep vein thrombosis in patients with superficial thrombophlebitis of the leg. Br Med J (Clin Res Ed). 1986;292(6521):658-9. http://dx.doi.org/10.1136/bmj.292.6521.658-a. PMid:3081214.

Prountjos P, Bastounis E, Hadjinikolaou L, Felekuras E, Balas P. Superficial venous thrombosis of the lower extremities co-existing with deep venous thrombosis. A phlebographic study on 57 cases. Int Angiol. 1991;10(2):63-5. PMid:1861087.

Skillman JJ, Kent KC, Porter DH, Kim D. Simultaneous occurrence of superficial and deep thrombophlebitis in the lower extremity. J Vasc Surg. 1990;11(6):818-23, discussion 823-4. http://dx.doi.org/10.1016/0741-5214(90)90079-P. PMid:2193177.

Chengelis DL, Bendick PJ, Glover JL, Brown OW, Ranval TJ. Progression of superficial venous thrombosis to deep vein thrombosis. J Vasc Surg. 1996;24(5):745-9. http://dx.doi.org/10.1016/S0741-5214(96)70007-1. PMid:8918318.

Verlato F, Zucchetta P, Prandoni P, et al. An unexpectedly high rate of pulmonary embolism in patients with superficial thrombophlebitis of the thigh. J Vasc Surg. 1999;30(6):1113-5. http://dx.doi.org/10.1016/S0741-5214(99)70051-0. PMid:10587397.

Unno N, Mitsuoka H, Uchiyama T, et al. Superficial thrombophlebitis of the lower limbs in patients with varicose veins. Surg Today. 2002;32(5):397-401. http://dx.doi.org/10.1007/s005950200061. PMid:12061687.

Sobreira ML, Maffei FH, Yoshida WB, et al. Prevalence of deep vein thrombosis and pulmonary embolism in superficial thrombophlebitis of the lower limbs: prospective study of 60 cases. Int Angiol. 2009;28(5):400-8. PMid:19935595.

Di Minno MN, Ambrosino P, Ambrosini F, Tremoli E, Di Minno G, Dentali F. Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis. J Thromb Haemost. 2016;14(5):964-72. http://dx.doi.org/10.1111/jth.13279. PMid:26845754.

Schardt C, Adams MB, Owens T, Keitz S, Fontelo P. Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak. 2007;7(1):16. http://dx.doi.org/10.1186/1472-6947-7-16. PMid:17573961.

Mateus A, Sanchez JP. POEMs: glossário e níveis de evidência. Rev Port Med Geral Fam. 2006;22:402-4.

Sandor T. Superficial venous thrombosis. A state of art. Orv Hetil. 2017;158(4):129-38. PMid:28116936.

Raffetto JD, Eberhardt RT. Benefit of anticoagulation for the treatment of lower extremity superficial venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2015;3(2):236-41. http://dx.doi.org/10.1016/j.jvsv.2014.11.005. PMid:26993846.

Leon L, Giannoukas AD, Dodd D, Chan P, Labropoulos N. Clinical significance of superficial vein thrombosis. Eur J Vasc Endovasc Surg. 2005;29(1):10-7. http://dx.doi.org/10.1016/j.ejvs.2004.09.021. PMid:15570265.

Milio G, Siragusa S, Mina C, et al. Superficial venous thrombosis: prevalence of common genetic risk factors and their role on spreading to deep veins. Thromb Res. 2008;123(2):194-9. http://dx.doi.org/10.1016/j.thromres.2008.01.013. PMid:18387654.

Decousus H, Quere I, Presles E, et al. Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study. Ann Intern Med. 2010;152(4):218-24. http://dx.doi.org/10.7326/0003-4819-152-4-201002160-00006. PMid:20157136.

Kobayasi S, Sadatsune T, Sicchieri C, et al. Complicações do cateterismo venoso. Estudo prospectivo de 202 casos. Rev Assoc Med Bras. 1980;26:366-8.

Decousus H, Bertoletti L, Frappe P, et al. Recent findings in the epidemiology, diagnosis and treatment of superficial-vein thrombosis. Thromb Res. 2011;127(Suppl 3):S81-5. http://dx.doi.org/10.1016/S0049-3848(11)70022-6. PMid:21262449.

Mouton WG, Kienle Y, Muggli B, Naef M, Wagner HE. Tumors associated with superficial thrombophlebitis. Vasa. 2009;38(2):167-70. http://dx.doi.org/10.1024/0301-1526.38.2.167. PMid:19588305.

Salemis NS, Vasilara G, Lagoudianakis E. Mondor’s disease of the breast as a complication of ultrasound-guided core needle biopsy: management and review of the literature. Breast Dis. 2015;35(1):73-6. http://dx.doi.org/10.3233/BD-140374. PMid:24989360.

Sobreira ML, Rogatto SR, Dos Santos RM, Santos IT, Ferrari IC, Yoshida WB. An unexpectedly high rate of thrombophilia disorders in patients with superficial vein thrombosis of the lower extremities. Ann Vasc Surg. 2017;43:272-7. http://dx.doi.org/10.1016/j.avsg.2017.02.022. PMid:28501666.

Turay UY, Erdogan Y, Ergün P, Biber C, Ciftçi B, Ayaz A. Lemierre’s syndrome. Respirol. 2001;6(2):171-3. http://dx.doi.org/10.1046/j.1440-1843.2001.00320.x. PMid:11422899.

Nakamura S, Sadoshima S, Doi Y, et al. Internal jugular vein thrombosis, Lemierre’s syndrome; oropharyngeal infection with antibiotic and anticoagulation therapy--a case report. Angiol. 2000;51(2):173-7. http://dx.doi.org/10.1177/000331970005100212. PMid:10701727.

Oldfield M. Mondor’s disease: a superficial phlebitis of the breast. Lancet. 1962;279(7237):994-6. http://dx.doi.org/10.1016/S0140-6736(62)92034-2. PMid:14481707.

Shionoya S. Buerger’s disease: diagnosis and management. Cardiovasc Surg. 1993;1(3):207-14. PMid:8076031.

Godoy JM, Batigalia F, Braile DM. Superficial thrombophlebitis and anticardiolipin antibodies--report of association. Angiol. 2001;52(2):127-9. http://dx.doi.org/10.1177/000331970105200206. PMid:11228085.

Godoy JMP, Batigália F, Braile DM. Protein S deficiency in repetitive superficial thrombophlebitis. Clin Appl Thromb Hemost. 2003;9(1):61-2. http://dx.doi.org/10.1177/107602960300900108. PMid:12643325.

Baglin T, Gray E, Greaves M, et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol. 2010;149(2):209-20. http://dx.doi.org/10.1111/j.1365-2141.2009.08022.x. PMid:20128794.

de Moerloose P, Wutschert R, Heinzmann M, Perneger T, Reber G, Bounameaux H. Superficial vein thrombosis of lower limbs: influence of factor V Leiden, factor II G20210A and overweight. Thromb Haemost. 1998;80(2):239-41. PMid:9716145.

Martinelli I, Cattaneo M, Taioli E, De Stefano V, Chiusolo P, Mannucci PM. Genetic risk factors for superficial vein thrombosis. Thromb Haemost. 1999;82(4):1215-7. PMid:10544900.

Tait C, Baglin T, Watson H, et al. Guidelines on the investigation and management of venous thrombosis at unusual sites. Br J Haematol. 2012;159(1):28-38. http://dx.doi.org/10.1111/j.1365-2141.2012.09249.x. PMid:22881455.

Paschoa AF, Guillaumon AT. Impact of screening on thrombophilia for patients with venous thrombosis. Int Angiol. 2006;25(1):52-9. PMid:16520725.

Federici C, Gianetti J, Andreassi MG. Genomic medicine and thrombotic risk: who, when, how and why? Int J Cardiol. 2006;106(1):3-9. http://dx.doi.org/10.1016/j.ijcard.2004.11.038. PMid:16102857.

Leon LR Jr, Labropoulos N. Superficial vein thrombosis and hypercoagulable states: the evidence. Perspect Vasc Surg Endovasc Ther. 2005;17(1):43-6. http://dx.doi.org/10.1177/153100350501700108. PMid:15952695.

Paschoa AF. Impacto da pesquisa laboratorial de trombofilia na prevenção secundária e orientação dos doentes com tromboembolismo venoso. São Paulo: UNICAMP; 2006.

Wu O, Robertson L, Twaddle S, et al. Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis. Br J Haematol. 2005;131(1):80-90. http://dx.doi.org/10.1111/j.1365-2141.2005.05715.x. PMid:16173967.

Walker ID, Greaves M, Preston FE. Investigation and management of heritable thrombophilia. Br J Haematol. 2001;114(3):512-28. http://dx.doi.org/10.1046/j.1365-2141.2001.02981.x. PMid:11552975.

Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA. 2005;293(19):2352-61. http://dx.doi.org/10.1001/jama.293.19.2352. PMid:15900005.

van Langevelde K, Lijfering WM, Rosendaal FR, Cannegieter SC. Increased risk of venous thrombosis in persons with clinically diagnosed superficial vein thrombosis: results from the MEGA study. Blood. 2011;118(15):4239-41. http://dx.doi.org/10.1182/blood-2011-05-356071. PMid:21849479.

Decousus H, Epinat M, Guillot K, Quenet S, Boissier C, Tardy B. Superficial vein thrombosis: risk factors, diagnosis, and treatment. Curr Opin Pulm Med. 2003;9(5):393-7. http://dx.doi.org/10.1097/00063198-200309000-00009. PMid:12904709.

Leizorovicz A, Becker F, Buchmuller A, Quéré I, Prandoni P, Decousus H. Clinical relevance of symptomatic superficial-vein thrombosis extension: lessons from the CALISTO study. Blood. 2013;122(10):1724-9. http://dx.doi.org/10.1182/blood-2013-04-498014. PMid:23821661.

Galanaud JP, Genty C, Sevestre MA, et al. Predictive factors for concurrent deep-vein thrombosis and symptomatic venous thromboembolic recurrence in case of superficial venous thrombosis. The OPTIMEV study. Thromb Haemost. 2011;105(1):31-9. http://dx.doi.org/10.1160/TH10-06-0406. PMid:20886192.

Galanaud JP, Sevestre MA, Pernod G, et al. Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis. J Thromb Haemost. 2017;15(6):1123-31. http://dx.doi.org/10.1111/jth.13679. PMid:28317330.

Gorski G, Noszczyk W, Kostewicz W, et al. Progress of local symptoms of superficial vein thrombosis vs. duplex findings. Vasa. 2004;33(4):219-25. http://dx.doi.org/10.1024/0301-1526.33.4.219. PMid:15623197.

Quenet S, Laporte S, Decousus H, Leizorovicz A, Epinat M, Mismetti P. Factors predictive of venous thrombotic complications in patients with isolated superficial vein thrombosis. J Vasc Surg. 2003;38(5):944-9. http://dx.doi.org/10.1016/S0741-5214(03)00607-4. PMid:14603198.

Belcaro G, Nicolaides AN, Errichi BM, et al. Superficial thrombophlebitis of the legs: a randomized, controlled, follow-up study. Angiol. 1999;50(7):523-9. http://dx.doi.org/10.1177/000331979905000701. PMid:10431991.

Bauersachs RM. Diagnosis and treatment of superficial vein thrombosis. Hamostaseologie. 2013;33(3):232-40. http://dx.doi.org/10.5482/HAMO-13-04-0027. PMid:23757000.

White JM, Comerota AJ. Venous Compression Syndromes. Vasc Endovascular Surg. 2017;51(3):155-68. http://dx.doi.org/10.1177/1538574417697208. PMid:28330436.

Gillet JL, Perrin M, Cayman R. Superficial venous thrombosis of the lower limbs: prospective analysis in 100 patients. J Mal Vasc. 2001;26(1):16-22. PMid:11240525.

Bergqvist D, Brunkwall J, Jensen N, Persson NH. Treatment of superficial thrombophlebitis. A comparative trial between placebo, Hirudoid cream and piroxicam gel. Ann Chir Gynaecol. 1990;79(2):92-6. PMid:1696799.

Becherucci A, Bagilet D, Marenghini J, Diab M, Biancardi H. Effect of topical and oral diclofenac on superficial thrombophlebitis caused by intravenous infusion. Med Clin (Barc). 2000;114(10):371-3. http://dx.doi.org/10.1016/S0025-7753(00)71300-5. PMid:10786346.

Titon JP, Auger D, Grange P, et al. Therapeutic management of superficial venous thrombosis with calcium nadroparin. Dosage testing and comparison with a non-steroidal anti-inflammatory agent. Ann Cardiol Angeiol (Paris). 1994;43(3):160-6. PMid:8024227.

Decousus H, Prandoni P, Mismetti P, et al. Fondaparinux for the treatment of superficial-vein thrombosis in the legs. N Engl J Med. 2010;363(13):1222-32. http://dx.doi.org/10.1056/NEJMoa0912072. PMid:20860504.

Wichers IM, Di Nisio M, Buller H, Middeldorp S. Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review. Haematologica. 2005;90(5):672-7. PMid:15921382.

Boehler K, Kittler H, Stolkovich S, Tzaneva S. Therapeutic effect of compression stockings versus no compression on isolated superficial vein thrombosis of the legs: a randomized clinical trial. Eur J Vasc Endovasc Surg. 2014;48(4):465-71. http://dx.doi.org/10.1016/j.ejvs.2014.06.047. PMid:25116277.

Belcaro G, Nicolaides AN, Geroulakos G, et al. Essaven gel--review of experimental and clinical data. Angiol. 2001;52(Suppl 3):S1-4.

Villardell M, Sabat D, Arnaiz JA, et al. Topical heparin for the treatment of acute superficial phlebitis secondary to indwelling intravenous catheter. A double-blind, randomized, placebo-controlled trial. Eur J Clin Pharmacol. 1999;54(12):917-21. http://dx.doi.org/10.1007/s002280050575. PMid:10192751.

Superficial Thrombophlebitis Treated by Enoxaparin Study Group. A pilot randomized double-blind comparison of low-molecular-weight heparin, a non-steroidal anti-inflammatory agent, and placebo in the treatment of superficial-vein thrombosis. Arch Intern Med. 2003;163(14):1657-63. http://dx.doi.org/10.1001/archinte.163.14.1657. PMid:12885680.

Prandoni P, Tormene D, Pesavento R, Vesalio Investigators Group. High vs. low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs: a double-blind, randomized trial. J Thromb Haemost. 2005;3(6):1152-7. http://dx.doi.org/10.1111/j.1538-7836.2005.01391.x. PMid:15946202.

Marchiori A, Verlato F, Sabbion P, et al. High versus low doses of unfractionated heparin for the treatment of superficial thrombophlebitis of the leg. A prospective, controlled, randomized study. Haematologica. 2002;87(5):523-7. PMid:12010667.

Andreozzi GM, Signorelli S, Di Pino L, et al. Tolerability and clinical efficacy of desmin in the treatment of superficial thrombovaricophlebitis. Angiol. 1996;47(9):887-94. http://dx.doi.org/10.1177/000331979604700907. PMid:8810655.

Kakkos SK, Kirkilesis GI, Tsolakis IA. Editor’s Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials. Eur J Vasc Endovasc Surg. 2014;48(5):565-75. http://dx.doi.org/10.1016/j.ejvs.2014.05.001. PMid:24951377.

Beyer-Westendorf J, Schellong SM, Gerlach H, et al. Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial. Lancet Haematol. 2017;4(3):e105-13. http://dx.doi.org/10.1016/S2352-3026(17)30014-5. PMid:28219692.

Belcaro G, Errichi B, Laurora G, Cesarone MR, Candiani C. Treatment of acute superficial thrombosis and follow-up by computerized thermography. VASA. 1989;18(3):227-34. PMid:2678804.

Lozano FS, Almazan A. Low-molecular-weight heparin versus saphenofemoral disconnection for the treatment of above-knee greater saphenous thrombophlebitis: a prospective study. Vasc Endovascular Surg. 2003;37(6):415-20. http://dx.doi.org/10.1177/153857440303700605. PMid:14671696.
 

5dde68a70e8825b92a7b23c8 jvb Articles

J Vasc Bras

Share this page
Page Sections